Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123M
-
Number of holders
-
128
-
Total 13F shares, excl. options
-
62.8M
-
Shares change
-
+1.16M
-
Total reported value, excl. options
-
$236M
-
Value change
-
-$30.8M
-
Put/Call ratio
-
3.46
-
Number of buys
-
75
-
Number of sells
-
-50
-
Price
-
$3.75
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q4 2019
151 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2019.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.8M shares
of 123M outstanding shares and own 51.01% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.44M shares), STATE STREET CORP (7.42M shares), ARMISTICE CAPITAL, LLC (5.1M shares), VANGUARD GROUP INC (4.81M shares), MORGAN STANLEY (2.86M shares), Nuveen Asset Management, LLC (2.15M shares), GOLDMAN SACHS GROUP INC (1.93M shares), PRUDENTIAL FINANCIAL INC (1.77M shares), MARSHALL WACE, LLP (1.57M shares), and MANGROVE PARTNERS (1.55M shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.